Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
12651
PUT
HUTCHMED
HCM
$2.54B
| $21.5K | ﹤0.01% |
1,100
-1,300
| -54% | -$23.5K |
2022 Q4
7 quarters
|
|
12652
CALL
SOPHiA GENETICS
SOPH
$628M
| $21.4K | ﹤0.01% |
+5,900
| New | +$24K |
2024 Q3
0 quarters
|
|
12653
Medallion Financial
MFIN
$271M
| $21.4K | ﹤0.01% |
2,633
-43,340
| -94% | -$344K |
2023 Q1
6 quarters
|
|
12654
CALL
Dyadic International
DYAI
$18.2M
| $21.4K | ﹤0.01% |
20,600
+9,200
| +81% | +$12.3K |
2021 Q1
14 quarters
|
|
|
AXDX
12655
DELISTED
Accelerate Diagnostics
AXDX
| $21.4K | ﹤0.01% |
+12,512
| New | +$18.5K |
2024 Q3
0 quarters
|
|
|
AAT
12656
PUT
American Assets Trust
AAT
$1.32B
| $21.4K | ﹤0.01% |
800
-3,800
| -83% | -$96.4K |
2023 Q2
5 quarters
|
|
12657
Cabaletta Bio
CABA
$342M
| $21.3K | ﹤0.01% |
4,511
-315,035
| -99% | -$1.82M |
2023 Q3
4 quarters
|
|
12658
CALL
Ecovyst
ECVT
$1.14B
| $21.2K | ﹤0.01% |
+3,100
| New | +$23.6K |
2024 Q3
0 quarters
|
|
12659
CALL
Bionano Genomics
BNGO
$17.1M
| $21.2K | ﹤0.01% |
778
-192
| -20% | -$5.97K |
2021 Q1
14 quarters
|
|
12660
PUT
Shenandoah Telecom
SHEN
$637M
| $21.2K | ﹤0.01% |
1,500
+600
| +67% | +$9.91K |
2024 Q2
1 quarter
|
|
12661
PUT
Ardagh Metal Packaging
AMBP
$2.65B
| $21.1K | ﹤0.01% |
5,600
-14,000
| -71% | -$49.5K |
2021 Q4
11 quarters
|
|
12662
PUT
Anixa Biosciences
ANIX
$105M
| $21.1K | ﹤0.01% |
+6,700
| New | +$20.6K |
2024 Q3
0 quarters
|
|
12663
Milestone Scientific
MLSS
$33.3M
| $21.1K | ﹤0.01% |
23,164
-31,169
| -57% | -$29.2K |
2023 Q2
5 quarters
|
|
|
FARO
12664
CALL
DELISTED
Faro Technologies
FARO
| $21.1K | ﹤0.01% |
1,100
+100
| +10% | +$1.69K |
2022 Q4
7 quarters
|
|
12665
PUT
BancFirst
BANF
$3.59B
| $21.1K | ﹤0.01% |
+200
| New | +$20.3K |
2024 Q3
0 quarters
|
|
12666
Smith Micro Software
SMSI
$14.6M
| $21K | ﹤0.01% |
+4,117
| New | +$29K |
2024 Q3
0 quarters
|
|
12667
Presidio Property Trust
SQFT
$1.35M
| $21K | ﹤0.01% |
2,919
-437
| -13% | -$2.99K |
2024 Q1
2 quarters
|
|
12668
CALL
GoPro
GPRO
$272M
| $20.9K | ﹤0.01% |
15,400
+3,900
| +34% | +$5.37K |
2014 Q3
40 quarters
|
|
|
RJET
12669
PUT
Republic Airways Holdings
RJET
$824M
| $20.9K | ﹤0.01% |
1,153
+440
| +62% | +$9.06K |
2022 Q3
8 quarters
|
|
12670
CALL
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.88B
| $20.9K | ﹤0.01% |
800
+500
| +167% | +$12.9K |
2024 Q2
1 quarter
|
|
|
DRRX
12671
PUT
DELISTED
DURECT Corp
DRRX
| $20.9K | ﹤0.01% |
15,600
+10,400
| +200% | +$14.8K |
2022 Q4
7 quarters
|
|
12672
CALL
Taysha Gene Therapies
TSHA
$1.43B
| $20.9K | ﹤0.01% |
10,400
-5,500
| -35% | -$12.1K |
2022 Q1
10 quarters
|
|
|
FBRT
12673
PUT
Franklin BSP Realty Trust
FBRT
$510M
| $20.9K | ﹤0.01% |
1,600
-8,300
| -84% | -$109K |
2022 Q3
8 quarters
|
|
|
CMLS
12674
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $20.9K | ﹤0.01% |
15,933
-9,303
| -37% | -$15.9K |
2022 Q3
8 quarters
|
|
12675
PUT
Interface
TILE
$2.03B
| $20.9K | ﹤0.01% |
1,100
+900
| +450% | +$15.5K |
2022 Q3
8 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.